Vddi Pharmaceuticals

Brentwood, TN 37027

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $510K
First Award Date 08/01/00
Most Recent Award Date 09/26/14

Key Personnel

Last Name Name Awards Contact
Porter R Stephen Porter 1

2 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-054
Budget: 09/26/14 - 08/31/15

DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to establish the feasibility of developing a small-molecule therapeutic agent designed to prevent rhabdomyolysis-induced renal failure. Rhabdomyolysis accounts for 7% to 10% of cases of renal failure in the US. Rhabdomyolysis results from muscle injury that leads to th...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-98-073
Budget: 08/01/00 - 02/28/01

Anthrax, according to many military and counterterrorism planners, represents the single greatest biological warfare threat. The long-term goal of this research effort is to develop pharmaceuticals that can be used prophylactically to prevent or to treat infection from Baccilis anthracis. A novel enzyme target, NAD synthetase (NADs), has been id...